Overview

A Midazolam Drug Interaction Study With PF-04171327

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effects of multiple doses of PF-04171327 on the blood levels (pharmacokinetics) of midazolam
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Midazolam